Our findings support the important concept for AD that after the earlier deposition of Aβ, astrocytes and microglia activate to clear Aβ until their functions are not powerful enough to remove Aβ deposition, and then tau-related pathology and neuronal loss occur, resulting in AD-type cognitive impairment. The gene discussed is MAPT; the disease is Cognitive impairment.